Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Cerilliant
Fish and Richardson
Chubb
Federal Trade Commission
Teva
Harvard Business School
Merck
Johnson and Johnson

Generated: May 23, 2018

DrugPatentWatch Database Preview

SUFENTANIL CITRATE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Sufentanil Citrate patents expire, and when can generic versions of Sufentanil Citrate launch?

Sufentanil Citrate is a drug marketed by Hospira, Watson Labs, and West-ward Pharms Int. and is included in three NDAs.

The generic ingredient in SUFENTANIL CITRATE is sufentanil citrate. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the sufentanil citrate profile page.
Drug patent expirations by year for SUFENTANIL CITRATE
Pharmacology for SUFENTANIL CITRATE
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Medical Subject Heading (MeSH) Categories for SUFENTANIL CITRATE
Synonyms for SUFENTANIL CITRATE
2-hydroxypropane-1,2,3-tricarboxylic acid; N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide
4074AH
56030-54-7 (Parent)
60561-17-3
AC1L23CS
AK319907
AKOS027325565
API0004254
ARX-01
ARX-02
ARX-F01
C22H30N2O2S.C6H8O7
CAS-60561-17-3
CHEBI:9317
CHEMBL1201163
CITRIC ACID; SUFENTANIL
CS-3051
D00845
D01SJC
DSSTox_CID_28854
DSSTox_GSID_48928
DSSTox_RID_83123
DTXSID5048928
EINECS 262-295-4
EN-3270
Fentatienil
FT-0674738
HE072000
HMS2272F05
HY-13754A
LS-124419
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropionamide citrate
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)-N-phenylpropionamide citrate
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide citrate
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide citrate (1:1)
N-(4-(Methoxymethyl)-1-(2-(thiophen-2-yl)ethyl)piperidin-4-yl)-N-phenylpropionamide 2-hydroxypropane-1,2,3-tricarboxylate
N-(4-(methoxymethyl)-1-(2-(thiophen-2-yl)ethyl)piperidin-4-yl)-N-phenylpropionamide citrate
N-[4-(Methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenyl, propanamide 2-Hydroxy-1,2,3-propanetricarboxylate
OJCZPLDERGDQRJ-UHFFFAOYSA-N
Propanamide, N-(4-(methoxymethyl)-1-(2-(thienyl)ethyl)-4-piperidinyl)-N-phenyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
Propionanilide, N-(4-(methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)-, citrate
R 30730 citrate salt
R 33800
R-33800
R33800
S9ZFX8403R
SCHEMBL41227
Sufenta
Sufenta Preservative Free
Sufentanil (citrate)
Sufentanil citrate (USP)
Sufentanil citrate [USAN:USP]
Sufentanil citrate [USAN]
Sufentanil Citrate 0.1 mg/ml in Methanol (as free base)
Sufentanil Citrate solution, 100 mug/mL in methanol (as free base), ampule of 1 mL, certified reference material
Sufentanil Forte
Sufentanil TDS
Sufentanil transdermal patch
SUFENTANILCITRATE
Sufentanyl Citrat
Sufentanyl citrate
Tox21_112879
TRANSDUR-Sufentanil
UNII-S9ZFX8403R

US Patents and Regulatory Information for SUFENTANIL CITRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira SUFENTANIL CITRATE sufentanil citrate INJECTABLE;INJECTION 074534-001 Dec 11, 1996 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs SUFENTANIL CITRATE sufentanil citrate INJECTABLE;INJECTION 074406-001 Dec 15, 1995 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
West-ward Pharms Int SUFENTANIL CITRATE sufentanil citrate INJECTABLE;INJECTION 074413-001 Dec 15, 1995 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Fish and Richardson
Federal Trade Commission
Moodys
Medtronic
Johnson and Johnson
Argus Health
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.